When David Fajgenbaum and his colleagues launched the drug repurposing non-profit Every Cure, they chose a path that ...
The study is a promising breakthrough that could eventually prove key to understanding the disease’s mysterious origins, its ...
Accelerated drug discovery and development platform Converge Bio Inc. today announced it has raised $25 million in early-stage funding to develop better drugs for pharmaceutical companies and open up ...
Researchers from Seoul National University Hospital have designed a machine learning model that predicts an individual's likely response to an anticonvulsant drug, aiming to reduce trials and errors ...
Using artificial intelligence to create new drugs may be the technology’s most important and marketable use. The idea isn’t merely hypothetical anymore, either. It’s now commercialized, even if still ...
Jan 6 (Reuters) - Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that uses artificial intelligence on genetic data to discover new drug candidates to send into human ...
Biopharmaceutical artificial intelligence startup Owkin Inc. said today it’s making a series of autonomous agents focused on drug discovery and research available to the broader healthcare industry, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results